New antipsychotic medications: strategies for evaluation and selected findings
- 30 October 1997
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 27 (2-3) , 249-259
- https://doi.org/10.1016/s0920-9964(97)00089-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Rationale and Ethics of Medication-Free Research in SchizophreniaArchives of General Psychiatry, 1997
- Treatment-resistant schizophrenia: clinical experience with new antipsychoticsEuropean Neuropsychopharmacology, 1996
- Risperidone in Elderly Schizophrenic Patients: An Open-Label TrialAmerican Journal of Geriatric Psychiatry, 1996
- Risperidone: A New, Novel (and Better?) AntipsychoticPsychiatric Annals, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Risk of Tardive Dyskinesia in Older PatientsArchives of General Psychiatry, 1995
- Neuroleptic Withdrawal in Schizophrenic PatientsArchives of General Psychiatry, 1995
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United StatesNew England Journal of Medicine, 1993
- Fluphenazine and Social Therapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1979